Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
23 participants
INTERVENTIONAL
2022-03-28
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate, using a custom-designed questionnaire, the feasibility and patient satisfaction with the rehabilitative treatment delivered via telemedicine compared to the same treatment delivered in person.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telerehabilitation in Mild Cognitive Impairment
NCT03486704
Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis
NCT06964581
Effects of Telerehabilitation on Brain Network Connectivity
NCT06278818
Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia
NCT03430401
Virtual Reality Rehabilitation for Cognitive, Emotional, and Motor Recovery in Neurological Disorders
NCT06838975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telerehabilitation group
Three hours of cognitive rehabilitation per week, performed remotely and independently, using a computerized device, which is pre-programmed based on the patient's needs.
Telerehabilitation
Three hours of cognitive rehabilitation per week, performed remotely and independently, using a computerized device, which is pre-programmed based on the patient's needs.
In-person treatment
Three hours of in-person cognitive rehabilitation per week using a computerized device.
Traditional in-person rehabilitation.
Three hours of in-person cognitive rehabilitation per week using a computerized device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telerehabilitation
Three hours of cognitive rehabilitation per week, performed remotely and independently, using a computerized device, which is pre-programmed based on the patient's needs.
Traditional in-person rehabilitation.
Three hours of in-person cognitive rehabilitation per week using a computerized device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 90 years;
* First stroke event;
* Stroke occurred more than 30 days ago;
* Adequate level of understanding;
* Presence of one or more of the following cognitive disorders:
* Memory disorders
* Attention disorders
* Executive function disorders
* Availability of an internet connection at the patient's home necessary for the telemedicine procedures.
Exclusion Criteria
* Presence of pre-morbid cognitive decline;
* Psychiatric disorders in the medical history;
* Alcohol and/or drug abuse;
* Presence of severe uncorrected visual deficits.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universita di Verona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valentina Varalta
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sezione medicina fisica e riabilitativa dipartimento di neuroscienze
Verona, verona, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3623CESC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.